A complete application in a minute
Tailored resume and cover letter, ready to send.
Lonza Biologics Tuas Pte Ltd in Singapore is seeking a Section Lead for our cGMP Cell Therapy manufacturing team. You will guide daily operations, ensure compliance, and drive safe, efficient production across shifts.
You will collaborate with QA, Engineering and MSAT to resolve issues, review batch records, and support continuous improvement. Strong leadership and GMP knowledge are essential to maintain data integrity and right-first-time performance.
Location: Tuas, Singapore
Today, Lonza is a global leader in life sciences. Our greatest scientific solution is talented people working together, devising ideas that help businesses help people. In exchange, we let our people own their careers. Their ideas, big and small, improve the world. And that’s the kind of work we want to be part of.
Join our Singapore manufacturing team and contribute to the production of innovative cell therapies. As Section Lead, you will lead the daily operational and administrative activities of a cGMP Cell Therapy manufacturing team, ensuring safe, compliant and efficient production. You will partner with Quality Assurance, Engineering and Manufacturing Science and Technology (MSAT) to resolve issues, strengthen consistency across teams and deliver production objectives.
At Lonza, our people are our greatest strength. With 30+ sites across five continents, our globally connected teams work together every day to manufacture the medicines of tomorrow. Our core values of Collaboration, Accountability, Excellence, Passion and Integrity reflect who we are and how we work together. Everyone’s ideas, big or small, have the potential to improve millions of lives, and that’s the kind of work we want you to be part of.
Innovation thrives when people from all backgrounds bring their unique perspectives to the table. At Lonza, we value diversity and are committed to creating an inclusive environment for all employees. If you’re ready to help turn our customers’ breakthrough ideas into viable therapies, we look forward to welcoming you on board.